Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

<p>Raw log2LFQ values for kinases profiled by MIB/MS</p>

Saved in:
書目詳細資料
主要作者: Alyssa C. Flint (16676029) (author)
其他作者: Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author)
出版: 2025
主題:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Methods and Technology
Cell Cycle
CDKs and CDK inhibitors
Chemotherapy
Combination chemotherapy
Gene Technologies
High-throughput sequencing
Preclinical Models
Animal models of cancer
Proteomics
Rare Cancers
Translational Research
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:<p>Raw log2LFQ values for kinases profiled by MIB/MS</p>

相似書籍